PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

May 22, 2020

Primary Completion Date

September 21, 2021

Study Completion Date

September 21, 2021

Conditions
COVID19COVID-19COVID
Interventions
DRUG

Pacritinib

100 mg capsules

DRUG

Placebo

Placebo capsules matching pacritinib 100 mg capsules

Trial Locations (21)

10029

Mount Sinai Medical Center, New York

19141

Albert Einstein Medical Center, Philadelphia

21229

St. Agnes Healthcare, Baltimore

30303

Grady Memorial Hospital, Atlanta

32204

Ascension St. Vincent's Riverside Hospital, Jacksonville

45219

The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital, Cincinnati

46220

St. Vincent Medical Group, Inc, Indianapolis

48075

Providence Cancer Institute, Southfield

48109

University of Michigan, Ann Arbor

48236

Ascension St. John Hospital, Detroit

48374

Ascension Providence Hospital - Novi Campus, Novi

53215

Ascension St. Francis Hospital, Milwaukee

53405

Ascension All Saints, Racine

74104

St. John Medical Center, Tulsa

92868

St. Jude Hospital Yorba Linda dba St. Joseph Heritage Healthcare, Orange

02115

Brigham and Women's Hospital, Boston

07960

Atlantic Melanoma Center, Morristown

Overlook Medical Center, Morristown

07444

Chilton Medical Center, Pompton Plains

02903

Rhode Island Hospital, Providence

The Miriam Hospital, Providence

Sponsors

Lead Sponsor

All Listed Sponsors
lead

CTI BioPharma

INDUSTRY